The two main actors responsible for the development of clinical guidelines are the government and academics (i.e. the Korean Academy of Medical Sciences). Since 2004, clinical research centres in Korea have specialised in specific Health Insurance Review and Assessment Service (HIRA) is responsible for quality assurance and auditing of claims for publicly reimbursed medical services. Both HIRA and KOIHA undertake public reporting on health care providers.